Table 1.
miRNA | Mechanisms affected | Factors (or genes) involved | References |
---|---|---|---|
miR-190 |
|
pERK, β-arrestin2, pYY1, and Talin2 | (Zheng et al. 2010c; Zheng et al. 2010a; Zheng et al. 2010b) |
miR-133b |
|
ERK 1/2, TH, and DAT | (Sanchez-Simon et al. 2010) |
miR-15b and -181b |
|
FGF-2, MCP-2, and IL-6 | (Dave and Khalili 2010) |
| |||
miR-28, 125b, 150, and 382 |
|
IFN-α/β | (Wang et al. 2011b) |
| |||
miR-23b |
|
MOR | (Wu et al. 2008; Wu et al. 2009) |
| |||
let-7 |
|
MOR | (He et al. 2010) |
| |||
miR-339 |
|
MOR | Unpublished |
CYP2D6, cytochrome P450 2D6; DAT, dopamine transporter; Drd3, dopamine D3R; FosB, FBJ murine osteosarcoma viral oncogene homolog B; IFN, interferon; IL-6, Interleukin-6; MCP-2, monocyte chemoattractant protein-2; MOR, mu opioid receptor; pERK, phosphorylated ERK; pYY1, phosphorylated YY1; TH, tyrosine hydroxylase.